Company intelligence / Profile preview

Personalized Science

Chapel Hill, North Carolina, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Personalized Science is a private clinical diagnostics and precision medicine consulting firm founded by Myla Lai-Goldman. The company appears to advise clients on the development, commercialization, regulatory positioning, and market adoption of innovative diagnostics rather than developing its own therapeutic pipeline. Publicly available descriptions position the firm around personalized medicine, individualized healthcare, and successful adoption of novel diagnostic technologies. It is associated with Chapel Hill, North Carolina, and has been described as active and for-profit. For a biotech analyst, this is best understood as a small specialist healthcare consulting business focused on diagnostics strategy rather than a drug-development biotech company.

Industry: Consulting

Beyond the preview

Go deeper on Personalized Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Personalized Science.

Explore the full profile